Tech Company Financing Transactions
Molecular Templates Funding Round
Private investors participated in a $40 million funding round for Molecular Templates. The round was announced on 8/16/2017.
Transaction Overview
Company Name
Announced On
8/16/2017
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 16 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
9301 Amberglen Blvd. 100
Austin, TX 78729
USA
Austin, TX 78729
USA
Phone
Website
Email Address
Not Recorded
Overview
Molecular Templates Inc. is creating an entirely new generation of potent anti-cancer agents based on proprietary applied proteomics technologies.The novel therapeutic agents in development by MTI are aimed particularly at melanoma, prostate and other metastatic cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Poma
Chief Financial Officer
Adam Cutler
Chief Medical Officer
Roger Waltzman
Chief Operating Officer
Jason Kim
Browse more venture capital transactions:
Prev: 8/16/2017: VentureMed Group venture capital transaction
Next: 8/16/2017: HealthJoy venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs